[1]贾晓杰,刘志跃△.红花制剂在糖尿病及其并发症中的研究进展[J].西部中医药,2013,26(03):127.
 JIA Xiaojie,LIU Zhiyue.Research Progress of Safflower Preparation in Diabetes Mellitus and the Complication[J].Western Journal of Traditional Chinese Medicine,2013,26(03):127.
点击复制

红花制剂在糖尿病及其并发症中的研究进展
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年03期
页码:
127
栏目:
动态·研究进展
出版日期:
2013-03-15

文章信息/Info

Title:
Research Progress of Safflower Preparation in Diabetes Mellitus and the Complication
文章编号:
1004-6852(2013)03-0127-03
作者:
贾晓杰刘志跃△
内蒙古医科大学病理生理教研室,内蒙古 呼和浩特 010050
Author(s):
JIA Xiaojie LIU Zhiyue△
Department of Pathophysiology in Inner Mongolia Medical University, Hohhot 010050, China
关键词:
红花制剂糖尿病并发症
Keywords:
safflower preparation diabetes mellitus complication
分类号:
R587.1
文献标志码:
A
摘要:
综述近年来国内外研究进展,就红花制剂治疗糖尿病及其并发症的动物实验,临床效果,作用机制做一总结分析,探讨其作用特点,为从不同角度治疗糖尿病及其并发症拓展思路,也为临床广泛应用红花开辟空间。
Abstract:
We have reviewed the research progress at home and abroad in recent years and analyzed the animal experiment, clinical effects and mechanism of safflower preparation in treating diabetes mellitus and its complication, which could broaden the thinking of the therapy for diabetes mellitus and the complication in different angles, also the space of widely using safflower in clinic.

参考文献/References:

[1] 叶任高,陆再英.内科学[M].6 版.北京:人民卫生出版社,2004:787. [2] 林兰.中西医结合糖尿病学[M].北京:中国医药科技出版社,1999:535-547 [3] 康丽,颜晓燕,辛志伟.红花的药理作用研究进展[J].西南军医,2008,10(6):136-138. [4] 许金照.补虚活血化瘀法治疗 2 型糖尿病的理论与临床研究[D].南京:南京中医药大学,2012:62-63. [5] 徐筱玮,张德宪.糖胰康改善成人隐匿性自身免疫性糖尿病胰岛β细胞功能的临床研究[J].中国中西医结合杂志,2008,28(10):882-885. [6] 李惠林,张志玲,朱章志,等.活血降糖饮对实验性糖尿病大鼠作用及机制[J].中国组织工程研究与临床康复,2007,11(38):7589-7592. [7] 晋玉章,谢文利,何瑞波.西红花苷对高脂血 2 型糖尿病模型大鼠降血糖和降血脂作用[J].武警医学院学报,2009,18(3):197-199. [8] 徐青,钟磊.丹红注射液对 2 型糖尿病超敏 C- 反应蛋白的作用[J].现代中西医结合杂志,2008,17(19):2946-2947. [9] 张志英,董利平,杨海燕.丹红注射液对糖尿病患者血液流变学的影响[J].时珍国医国药,2007,18(9):2272-2273. [10]Yan SF,Ramasamy R,Naka Y,et al.Glycation,inflammation and RAGE:a scaffold for the macrovascular complications of diabetes and beyond[J].Circ Res,2003,93(12):1159-1169. [11]向敏,钱之玉,周成华.西红花酸对糖尿病大鼠体内晚期糖基化终产物的形成及其受体表达的影响[J].中国临床药理学与治疗学,2006,11(4):448-452. [12]向敏,周成华,钱之玉.西红花酸对晚期糖基化终产物诱导牛血管内皮细胞 E- 选择素表达的抑制作用[J].中国临床药理学与治疗学,2010,15(7):764-769. [13]张建德,汤文龙,伍宗明,等.丹红注射液治疗 2 型糖尿病下肢血管病变的临床研究[J].中国实用医药,2008,3(14):20-22. [14]卢勇,唐绍辉,钱洪津.红花注射液治疗糖尿病肾病肾衰竭的疗效观察[J].临床军医杂志,2010,38(2):240-242. [15] Tawfik MK.Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats[J].Eur Rev Med Pharmacol Sci,2012,16(5):600-609. [16]刘慎微,尹超,吴泽成,等.红花对 2 型糖尿病大鼠肾脏氧化应激反应的影响[J].中国药房,2009,20(6):409-411. [17]张建德,邓建华,伍宗明,等.丹红注射液对 2 型糖尿病肾病患者 CRP、TNF-琢 水平的影响[J].中国实用医药,2007,2(35):68-70. [18]楼南芳,柴国禄,刘淑芹.丹红注射液对糖尿病肾病患者血浆内皮素、一氧化氮水平的影响[J].中医药学报,2008,36(3):40-42. [19]郭登洲,王月华,边东,等.红花黄色素对糖尿病肾病大鼠血管紧张素系统的影响[J].中成药,2009,31(12):1832-1836. [20] Crawford TN,Alfaro DV 3rd,Kerrison JB,et al.Diabetic retinopathy and angiogenesis[J].Curr Diabetes Rev,2009,5(1):8-13. [21]黄沁园,黄敏丽,何纯刚.羟基红花黄色素 A 对高糖作用下视网膜微血管内皮细胞增殖的影响[J].国际眼科杂志,2011,11(8):1324-1326. [22]申进亮,庞国明.通血复明汤治疗增生期糖尿病性视网膜病变的体会[J].辽宁中医杂志,2011,38(12):2408-2409. [23]陈发胜,孙丰雷,魏爱生,等.红花注射液治疗糖尿病周围神经病变的机制探讨[J].中西医结合心脑血管病杂志,2003,1(8):456-458. [24]陈剑秋,石志芸,王文健,等.双红通治疗糖尿病周围神经病变的临床观察与实验研究[J].中成药,2002,24(8):601-604. [25]李长运,载天然,胡东南,等.丹红注射液保护糖尿病心肌病大鼠心肌细胞分析[J].中国现代医药杂志,2008,l0(12):27-31. [26]孙燕.丹红注射液治疗 2 型糖尿病合并冠心病的临床疗效及细胞因子水平变化[J].中国医学创新,2010,7(10):12-13. [27]李外琼,罗秀蓉,李萍,等.红花黄色素对糖尿病合并冠心病患者心绞痛的临床疗效观察[J].昆明医学院学报,2010,31(4):50-53. [28]潘庆敏,严洁,屈红.藏红花浸泡液治疗老年糖尿病下肢溃疡 18 例[J].中国老年学杂志,2011,31(20):4053-4054. [29]熊东林,彭辉,吴枢武.丹红注射液联合脑心通胶囊联合治疗糖尿病合并脑梗死临床观察[J].中国实用医药,2011,6(32):148-149. [30]刘玲.丹红注射液治疗糖尿病尿失禁 34 例[J].中医药临床杂志,2011,23(3):211.

相似文献/References:

[1]段尚勤.糖脂消合罗格列酮治疗2型糖尿病合并非酒精性脂肪肝疗效观察[J].西部中医药,2013,26(02):88.
 DUAN Shangqin.Clinical Observation on TangZhiXiao and Rosiglitazone Maleate in Treating Type 2 Diabetes Mellitus Complicated with Non Alcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(03):88.
[2]张军和,杨振亚,张永琴.安糖1号治疗初发2型糖尿病并代谢综合征40例临床观察[J].西部中医药,2013,26(05):1.
 ZHANGJunhe,YANGZhenya,ZHANGYongqin.ClinicalObservationonAnTangNo.1intheTreatmentfor40CasesofDiabetesMellitusTypeTwoatPrimaryStageComplicatedwithMetabolismSyndrome[J].Western Journal of Traditional Chinese Medicine,2013,26(03):1.
[3]吕志芹,魏文慧.胰岛素联合痰热清治疗2型糖尿病合并肺部感染49例[J].西部中医药,2013,26(06):85.
 LV Zhiqin,WEI Wenhui.Insulin and TanReQing Injection in Treating 49 Cases of Diabetes Mellitus Type Two Complicated with Pulmonary Infection[J].Western Journal of Traditional Chinese Medicine,2013,26(03):85.
[4]范宗慧.温肾健脾法治疗糖尿病心得[J].西部中医药,2012,25(09):43.
 FAN Zong-hui.Experience on Method of WenShen JianPi in Treating Diabetes[J].Western Journal of Traditional Chinese Medicine,2012,25(03):43.
[5]张国民.消渴清颗粒治疗糖尿病周围神经病变疗效分析[J].西部中医药,2012,25(08):66.
 ZHANG Guo-min.XiaoKeQing Granules in Treating Diabetic Peripheral Neuropathy[J].Western Journal of Traditional Chinese Medicine,2012,25(03):66.
[6]张载宏.丹红注射液联合多贝斯治疗糖尿病周围神经病变临床疗效观察[J].西部中医药,2013,26(07):74.
 ZHANG Zaihong.Clinical Observation on DanHong Injection and Calcium Dobesilate Capsules in Treating Diabetic Peripheral Neuropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):74.
[7]段丽萍.中西医结合治疗糖尿病周围神经病变30例[J].西部中医药,2013,26(07):90.
 DUAN Liping.Integrative Medicine in Treating 30 Cases of Diabetic Peripheral Neuropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(03):90.
[8]刘希宏.中西药物联用对老年高血压合并2型糖尿病患者肾功能的保护作用[J].西部中医药,2012,25(07):9.
 LIU Xi-hong.Protection of Integrated Traditional Chinese and Western Medicine on Renal Function of Patients with Senile Hypertension and Type 2 Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2012,25(03):9.
[9]龚云,王超,亢建国.运动结合灵芝多糖干预对糖尿病大鼠血脂的影响[J].西部中医药,2013,26(08):8.
 GONG Yun,WANG Chao,KANG Jianguo.Effects of Exercise and Ganoderan Intervention on Blood Fat of Rats with Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2013,26(03):8.
[10]呼宝娟.护理干预对肺结核合并糖尿病患者生活质量的影响[J].西部中医药,2013,26(09):125.
 HU Baojuan.Effects of Nursing Intervention on Life Quality of Diabetic Patients Complicated with Pulmonary Tuberculosis[J].Western Journal of Traditional Chinese Medicine,2013,26(03):125.

备注/Memo

备注/Memo:
收稿日期:2012-10-27 作者简介:贾晓杰(1982—),女,硕士研究生。研究方向:病理学与病理生理学。 △通讯作者:刘志跃(1957—),男,硕士研究生导师,硕士学位,教授。研究方向:心血管疾病病理生理学。
更新日期/Last Update: 2013-03-15